Corinne C. Ploix, PhD, PharmD
Affiliations: | Assay Development | Roche, Indianapolis, IN, United States |
Google:
"Corinne Ploix"Mean distance: 18.17 (cluster 11) | S | N | B | C | P |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Iwata Y, Harada A, Hara T, et al. (2016) Is an in vitro whole blood cytokine assay useful to detect the potential risk of severe infusion reaction of monoclonal antibody pharmaceuticals? The Journal of Toxicological Sciences. 41: 523-31 |
Ploix CC, Noor S, Crane J, et al. (2011) CNS-derived CCL21 is both sufficient to drive homeostatic CD4+ T cell proliferation and necessary for efficient CD4+ T cell migration into the CNS parenchyma following Toxoplasma gondii infection. Brain, Behavior, and Immunity. 25: 883-96 |
Ploix C, Zuberi RI, Liu FT, et al. (2009) Induction and effector phase of allergic lung inflammation is independent of CCL21/CCL19 and LT-beta. International Journal of Medical Sciences. 6: 85-92 |
Carson MJ, Doose JM, Melchior B, et al. (2006) CNS immune privilege: hiding in plain sight. Immunological Reviews. 213: 48-65 |
Ploix C, Lo D, Carson MJ. (2001) A ligand for the chemokine receptor CCR7 can influence the homeostatic proliferation of CD4 T cells and progression of autoimmunity. Journal of Immunology (Baltimore, Md. : 1950). 167: 6724-30 |
Bergerot I, Ploix C, Petersen J, et al. (1997) A cholera toxoid-insulin conjugate as an oral vaccine against spontaneous autoimmune diabetes Proceedings of the National Academy of Sciences of the United States of America. 94: 4610-4614 |